FindTrial
Sign In

The mechanism of HTRM9L regulates ovarian cancer cell proliferation, invasion and migration

The mechanism of HTRM9L regulates ovarian cancer cell proliferation, invasion and migration

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CRC-16008662
Enrollment
Unknown
Registered
2016-06-17
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Interventions

Case series:NA

Sponsors

University Town Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Ovarian epithelial Cancer

Exclusion criteria

Exclusion criteria: non Ovarian epithelial Cancer

Design outcomes

Primary

MeasureTime frame
hTRM9L;ovarian cancer cell proliferation, invasion and migration;—

Countries

China

Contacts

Public ContactJia Wang

University Town Hospital of Chongqing Medical University

752203031@qq.com+86 13508307321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026